Creating impact through customer centricity
Supporting pharma companies to develop impactful strategies for market leadership with the customer at the center, has been our passion at Trilations for more than 20 years.
With the 4th annual “Pharma Customer Centricity Index” (PCCI) survey, we want to provide pharma companies with an objective view on their ‘Customer Centricity’ performance and what is driving this.
Therefore, we collected insights on both physician & patient centricity, but also on customer relationship & (omnichannel) interaction, scientific leadership, and much more.
Pharma Customer Centricity Index 2023 scope
Countries: EU5, USA, Brazil, Japan, China, Australia
Treatment areas: Oncology, Haematology, Dermatology, Rheumatology, Cardiology, Neurology
Respondents: 1.729 spezialized physicians
You can consult your Pharma Customer Centricity Index scores and those of competing pharma companies in our report below.
If you are interested in more detailed results, want to find out what is driving this and how to improve, please reach out to us.